Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the

Andrew D Krahn1, Douglas S Lee, David Birnie

  • 1Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. akrahn@uwo.ca

Insights

Complications after implantable cardioverter-defibrillator (ICD) replacement are linked to angina, antiarrhythmic drugs, prior procedures, and low implanter volume. These major complications increase the risk of mortality.

Area of Science:

  • Cardiology
  • Medical Devices
  • Patient Safety

Background:

  • Implantable cardioverter-defibrillator (ICD) replacement complications can be severe, especially infections or reoperations.
  • Identifying high-risk patients for ICD replacement is crucial for targeted monitoring and therapy.
  • Predictive factors for adverse outcomes can aid clinical decision-making for ICD replacement.

Purpose of the Study:

  • To identify risk factors for complications following ICD generator replacement.
  • To assess the association between ICD replacement complications and subsequent mortality.

Main Methods:

  • Prospective, multicenter, population-based registry of ICD patients in Ontario, Canada (February 2007 - August 2009).
  • Examined 45-day complication and all-cause mortality rates after ICD generator replacement in 1081 patients.
  • Multivariable analysis and Cox models were used to identify risk factors and mortality associations.

Main Results:

  • 4.3% of patients experienced complications within 45 days of ICD replacement; 2.6% had major complications (most common: infection, lead revision).
  • Risk factors for major complications included Canadian Cardiovascular Society angina class and multiple previous pocket procedures.
  • Risk factors for any complication included antiarrhythmic therapy, low implanter volume, and angina class.

Conclusions:

  • Angina, antiarrhythmic therapy, prior procedures, and low implanter volume are associated with ICD replacement complications.
  • Major complications after ICD replacement are linked to an increased risk of mortality at 45, 90, and 180 days.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...